|
Research Article
|
|
Prevalence of Respiratory Syncytial Virus Infection in Riyadh During the Winter Season 2007-2008 and Different Risk Factors Impact
|
|
Fahad N. Al-Majhdi,
A. Al-Jarallah,
M. Elaeed,
A. Latif,
L. Gissmann
and
Haitham M. Amer
|
|
ABSTRACT
|
In the current study, two RT-PCR systems for detection (mono-specific) and typing (duplex) of RSV in clinical samples have been developed and validated. The two assays were exploited for studying the dissemination of RSV infection in Riyadh, Saudi Arabia during the winter season 2007/2008. Furthermore, the effect of certain risk factors, including gender, age and disease form, on extend and impact of the infection was analyzed. Of two hundreds collected samples, 70 (35%) were positive for RSV infection, among which 40 (57.1%) were type A and 30 (42.9%) were type B viruses. This investigation is the first that describes the existence of both RSV subtypes in co-ordinance in Saudi Arabia children, with slight dominance of type A viruses. By analyzing the effect of risk factors on the disease epidemiology we confirmed that males, patients at young age and asthmatics are more susceptible for RSV infection and disease progression.
|
|
|
|
How
to cite this article:
Fahad N. Al-Majhdi, A. Al-Jarallah, M. Elaeed, A. Latif, L. Gissmann and Haitham M. Amer, 2009. Prevalence of Respiratory Syncytial Virus Infection in Riyadh During the Winter Season 2007-2008 and Different Risk Factors Impact. International Journal of Virology, 5: 154-163. DOI: 10.3923/ijv.2009.154.163 URL: https://scialert.net/abstract/?doi=ijv.2009.154.163
|
|
|
INTRODUCTION
Respiratory Syncytial Virus (RSV) is a single stranded, non-segmented RNA virus
of negative-sense, which belongs to the Pneumovirinae subfamily of the Paramyxoviridae
family, Order Mononegavirales (Riffault et al.,
2006; Dimmock et al., 2007). It is recognized
as the most frequent cause of severe lower respiratory tract infections in humans,
particularly in young children, infants and immunocompromised individuals (Couch
et al., 1997; Han et al., 1999; Falsey
et al., 2005). According to the World Health Organization (WHO),
RSV is responsible for approximately 64 million cases and 160,000 deaths every
year worldwide. Respiratory syncytial virus infects more than 65% of infants
during the first year of life and nearly all children experience one or more
RSV infections by the end of the second year (Glezen et
al., 1986). Hospitalization rates of infants are usually variable with
the setting, with several developed countries having rates of 0.1-2% (Fisher
et al., 1997). These rates tend to be significantly higher for children
in lower socioeconomic groups and in developing countries (Boyce
et al., 2000; Hoffman et al., 2004).
Mortality due to RSV infection are usually uncommon but highly significant in
infants suffering from chronic lung diseases and congenital heart disease reaching
up to 40% (Kim et al., 1973; Fixler,
1996) in immunocompromised individuals it can reach 80-100% (Whimbey
et al., 1996).
Respiratory syncytial virus has a single serotype with two distinct antigenic
subgroups A and B identified by panels of monoclonal antibodies (Anderson
et al., 1985; Mufson et al., 1985).
Sequence analysis of representatives of the two subgroups showed that they share
high nucleotide and amino acid identity with a considerable divergence among
structural proteins like G, M2-2, SH and F (Johnson et
al., 1987; Collins et al., 1990). Some
studies suggest that subgroup A viruses are more virulent than subgroup B viruses
and replicate to higher titers in the respiratory tract (Walsh
et al., 1997). Nevertheless, viruses from both subgroups are usually
co-circulating during an epidemic with an alternating pattern regarding the
predominant subgroup every 1-2 years (Peret et al.,
1998; White et al., 2005). Therefore, characterization
and typing of the circulating RSV strains became a necessary tool for the epidemiological
investigations, a matter that enables better disease control strategies (Barr
et al., 2000).
Although, the effect of RSV infection in children is well understood, the need
for accurate and reliable virus detection and typing methods is still an urgent
issue. Culture methods are traditionally recognized as the gold standard for
virus isolation and diagnosis, however they are not generally acceptable in
every-day practice due to the required time, effort and costs (Welliver,
1988). Serological techniques such as direct immuno-fluorescence and antigen
capture ELISA may provide quicker results but they lack the desired sensitivity
and sometimes specificity (Johnson and Siegel, 1990;
Kuypers et al., 2006). During the last two decades,
molecular biology based-assays, particularly end-point and real-time PCR proved
their ability to overcome these limitations and provided simple and high-throughput
amenable tools in detection, typing and quantification of many respiratory viral
agents including RSV (Osiowy, 1998; Falsey
et al., 2002; Bellau-Pujol et al., 2005).
In the current study, two different RT-PCR systems were developed and optimized for detection (mono-specific) and typing (Duplex) of RSV in clinical samples. The developed assays were utilized in screening of 200 nasopharyngeal aspirates (NPAs) collected from hospitalized children with acute respiratory tract infections in Riyadh, KSA. Different risk factors were analyzed for their influence in disease predisposition. MATERIALS AND METHODS
Specimens
Nasopharyngeal aspirates were collected from 200 children aged from one
month to three years and hospitalized with suspected acute respiratory tract
infections during the period extended from late autumn of 2007 till spring of
2008. The aspirates were taken by trained nurses at King Khalid University Hospital,
Riyadh, Saudi Arabia, who inserted a sterile catheter into the nasal cavity
of patients to a depth of 5-7 cm and drawn back while applying gentle suction
using an electronic suction device (Heikkinen et al.,
2002). Specimens were transported in Minimal Essential Medium (MEM) supplemented
with 500 U penicillin and 500 μg streptomycin per mL to the Research Central
Laboratory, College of Science, King Saud University, Riyadh, where they processed,
tested and stored at -80°C.
RNA Extraction
Viral RNA was isolated from fresh and frozen samples using QIAamp Viral RNA
Mini Kit (Qiagen GmbH, Hilden, Germany). Each sample aliquot was used only once
to avoid the loss of viral genomic material during repetitive freezing and thawing.
The viral RNA extraction kit combines the selective binding properties of a
silica gel membrane with the speed of microspin technology. The procedure was
conducted utilizing 140 μL sample volumes according to the manufacturers
instructions. Purified RNA was eluted from QIAamp columns in 60 μL elution
buffer and stored at -20°C for use in mono-specific
and duplex RT-PCR assays.
Primer Selection and Synthesis
The primers used for identification and typing of RSV strains were selected
and optimized on the basis of GeneBank data of a wide variety of human RSV isolates.
A primer pair that amplifies a 279 bp fragment of Nucleocapsid (N) gene of RSV
was completely conserved for both RSV subtypes and used in mono-specific RT-PCR
(Cane and Pringle, 1991). Two different primer sets
were utilized for subtyping of RSV strains in a duplex RT-PCR: one for type
A RSV that amplifies a 413 bp fragment of Fusion (F) gene and the other amplifies
149 bp fragment of the type B RSV N gene (Templeton et
al., 2004) (Table 1).
First Strand Synthesis
The viral RNA extract was reverse transcribed using Sensiscript®
Reverse transcription kit (Qiagen GmbH, Hilden, Germany) according to the manufacturers
guidelines. A reaction mixture contained 5 μL of template RNA, 2 μL
of 10x buffer RT, 2 μL of 5 mM dNTPs mix, 200 μM of random primers,
10 U of RNase inhibitor and 1 μL of sensiscript® Reverse
Transcriptase was prepared and completed to 20 μL total reaction volume
by RNase free water. The mixture was incubated for 60 min at 37°C and then
cooled to 4°C till use in mono-specific or duplex PCR. The synthesized cDNA
products were analyzed by agarose gel electrophoresis for further confirmation.
Mono-Specific and Duplex PCR
Two RSV-specific PCR systems were developed and optimized in the current
study: the first utilized universal N gene primers and aimed for detection of
RSV infection in suspected samples (Mono-specific RSV-PCR), while the second
utilized the two primer sets that identify subtypes A and B of RSV simultaneously
in a single reaction tube (Duplex RSV-PCR). Both PCR reactions were set up using
Multiplex PCR kit (Qiagen, Hilden, Germany) with specific technical adaptations
for ideal amplification results. A final reaction volume of 50 μL containing
25 μL of 2xQiagen Multiplex PCR Master Mix, 2 μM of each specific
primer (universal N gene primers for mono-specific PCR and RSV-A and RSV-B primer
sets for duplex PCR), 2 μL of the cDNA product and 21 μL of RNase
free water was prepared for each sample.
Table 1: | Oligonucleotide
primers for mono-specific and duplex RT-PCR |
 |
Sample tubes were incubated in a thermal cycler (Primus 96plus, MWG AG Biotech,
Ebersberg, Germany) for one cycle at 95°C for 15 min followed by 35 cycles
of 94°C for 30 sec, 50°C for 90 sec and 72°C for 90 sec and finally
one cycle of 72°C for 10 min. The PCR products were separated in 1.5% agarose
gel containing 0.5 μg mL-1 ethidium bromide and corresponding
bands were identified as compared with 1 kbp DNA ladder (Invitrogen, San Diego,
CA, USA) using an image analysis system (IMAGO Compact Imaging System, B and
L, USA).
RESULTS AND DISCUSSION
Seasonal epidemics of RSV infection cost several thousands of lives throughout
the world every year, primarily among children with underlying cardiac, pulmonary
and immunologic disorders (De Vincenzo, 2007). A wide
range of risk factors either predispose or complicate the infection status including
age, gender, premature birth, passive smoking, lack of pure breast feeding,
disease form and medical history of respiratory diseases and allergy (Welliver,
1988; Meqdam and Subiah, 2006).
In Saudi Arabia, only few reports described the prevalence of RSV infection
in sporadic districts of the kingdom including Riyadh, Al-Quassim and Abha (Jamjoom
et al., 1993; Bakir et al., 1998;
Al-Hajjar et al., 1998; Al-Shehri
et al., 2006; Meqdam and Subiah, 2006). These
reports covered short periods of time extending from 1991-1996 and 2003-2004.
From these available data it appears that RSV is the main causative organism
involved in acute respiratory tract infections and hospitalization of young
children in Saudi Arabia with an incidence range of 28.5-54%. However, the use
of serological and virological assays of limited specificity and sensitivity
may impact the validity of these results. Currently, we are lacking important
information regarding the situation of RSV infection, the predominant subtypes
and impact of different risk factors on the disease status. No virus isolate
is available for characterization and vaccine preparation.
Since, RSV infection is highly contagious and usually requires hospitalization,
rapid and accurate diagnosis of the virus infection is very important for preventing
nosocomial infections, a matter that profoundly decreases extent and severity
of the infection in a community (Mlinaric-Galinovic et
al., 1996; Deiman et al., 2007). Moreover,
it enables the application of appropriate patient management, control measures
and helps to avoid the unnecessary use of antibiotics (Wilson
et al., 2002; Slinger et al., 2004;
Kafetzis, 2004).
With the advance of molecular biology and development of more specific and
sensitive techniques to test for viral pathogens, especially PCR, it is now
possible to examine the prevalence of different viruses implicating in respiratory
tract infection more accurately (Kitchin, 1990; Nadder
and Langly, 2001; Espey et al., 2006). Therefore, in the current
study we optimized a standard two-step RT-PCR assay for direct diagnosis of
RSV in clinical samples. Despite the preference of single-step RT-PCR in routine
diagnostic approaches (handling errors, contamination risks and work load issues
are significantly decreased) the two-step RT-PCR offers better flexibility and
quality control potential. In addition, lower primer-dimer formation and availability
of more stable cDNA libraries for sample archiving and epidemiological studies
are major advantages of the two-step approach (Vandesompele
et al., 2002).
The developed RT-PCR assay makes use of a primer set that amplifies a fragment
of 279 bp in the nucleocapsid gene sequence (Fig. 1). The
potential of the N gene for development of such an assay relies on the sequence
conservation and high level of expression accounting for better sensitivity
and specificity (Cane and Pringle, 1991; O`Shea
and Canea, 2004; Yamada et al., 2004; Dewhurst-Maridor
et al., 2004).
| Fig. 1: |
Mono-specific RT-PCR products of selected NPA samples for
detection of HRSV as shown by agarose gel electrophoresis: Lane M represents
1 kbp DNA molecular weight ladder plus, Invitrogen; Lanes 5, 7 and 10 show
positive amplification of a 279 bp fragment of HRSV-N gene sequence and
Lanes 1, 2, 3, 4, 6, 8 and 9 show negative results |
To further investigate the specificity of the assay, different human respiratory
viral agents were tested in parallel. No cross-reactivity could be observed
for Influenza A and B viruses, Parinfluenza-2 and 3, Human Metapneumoviruses
and Measles virus, indicating that the assay was specific for RSV.
Respiratory syncytial virus subtypes A and B occur either simultaneously or
alternate during the annual epidemics of RSV infection (Papadopoulos
et al., 2004). The available information concerning the clinical
severity, the geographical distribution and the chronology of either subtype
is still controversial (Walsh et al., 1997; White
et al., 2005). Typing of RSV-positive samples on temporal and spatial
bases will shed more light on the epidemiology of RSV infection and consequently
enable the design of comprehensive and long-term control strategies. Therefore,
we developed a duplex RT-PCR assay for the detection of both RSV subtypes, using
primer pairs that specifically differentiate between type A and B viruses (Fig.
2). The sensitivity, specificity and reproducibility of the assay was evaluated
and confirmed by the standard means.
For studying the prevalence of RSV in Riyadh, Saudi Arabia, during the winter
season of 2007-2008 and implication of some risk factors (e.g., gender, age
and disease form) on the infection status, we further exploited the aptitude
of the two developed RT-PCR systems for detection and typing of RSV in clinical
samples. Since, conduction of a investigation that covers all of Riyadh city
proved to be too difficult, we focused on the collection of samples from children
registered at King Khalid University Hospital, which is an educational hospital
that accepts patients from the whole Riyadh city and many nearby districts.
Of 200 tested NPA samples, 70 were positive for RSV infection (35%) (Table
2). This ratio is well in line with other studies that identify RSV as the
main causative agent in at least one quarter of respiratory infection cases
of hospitalized children in Saudi Arabia and worldwide (Holberg
et al., 1991; Bakir et al., 1998;
Al-Hajjar et al., 1998; Al-Shehri
et al., 2006; Hu et al., 2003; Mentel
et al., 2005).
Typing of the positive samples using duplex RT-PCR indicated that 57.1% were
type A viruses and 42.9% were type B. These results validate the implication
of both virus subtypes in RSV infection of Saudi Arabia children during the
winter season 2007-2008 with a slight dominance of type A viruses. No distinct
association between the virus subtype and clinical outcome could be observed
from our data, since, both subtypes were identified in cases of different disease
categories with comparable ratio.
| Fig. 2: | Duplex
RT-PCR products of four selected RSV-positive NPA samples using two primer
sets that identify types A and B viruses simultaneously, shown by agarose
gel electrophoresis: Lane M represents 1 Kbp DNA molecular weight marker;
Lanes 1 and 2: type B RSV viruses lanes 3 and 4: type A RSV viruses |
Table 2: | Influence
of different risk factors (Gender, age and disease form) on the prevalence
of RSV and its major subtypes in hospitalized children under study
|
 |
*No.:
Number, **RTI: Respiratory tract infection |
The study was also designed to evaluate the effect of different risk factors
like gender, age and disease form on the extent and impact of RSV infection
in Saudi Arabia children. For accomplishing such purpose, the samples used in
this study were collected in a balanced manner concerning each of these risk
factors. The only exception was the disease form category which includes higher
frequency of patients with lower respiratory tract infection since most of the
hospitalized children are basically suffering form bronchiolitis and/or pneumonia.
Regarding the gender risk factor, the results obtained delineate that male
patients (No. = 38/102; 38.7%) are at a slightly higher risk than female patients
(No. = 32/98; 31.3%), which appears in agreement with many previous investigations
(Wang and Law, 1998; Iwane et
al., 2004; Gerna et al., 2008). This
phenomenon was explained by Meissner (2003) in which
they indicated that the airways of young males are shorter and narrower than
those of young females leading to a worse evolution of the disease. Male being
of higher risk applies for both virus subtypes A and B (Table
2).
Respiratory Syncytial Virus infection is usually associated with children younger
than 5 years and particularly younger than one year (Wang
and Law, 1998). The age-distribution of RSV illness appears similar throughout
the world; however, there is no documented data demonstrating such similarity
in Saudi Arabia children. In this study, we grouped the samples into four main
age groups: 0-6 months; 6-12 months; 1-2 years and 2-3 years. The results showed
that 70% of the RSV-positive samples were collected from children younger than
one year and then the incidence decreases by developing in age (18.6% during
the second year and 11.4% during the third year). The same situation exists
for both subtypes A and B with significant higher preference of type B to less
younger ages.
Although, RSV is associated with all aspects of respiratory tract illness in
children, it is highly incriminated in most Lower Respiratory Tract (LRT) affections
as well as wheezing and asthma (Kim et al., 1973).
In the present study, the relative implication of RSV in LRT illness (28.5%)
was expected and nearly identical to the international rates (Holberg
et al., 1991). However, the remarkable observation is the significant
higher ratio of RSV-positive samples in asthmatic patients (73.3%). This supports
the idea that RSV is the predominant pathogen involved in wheezing and asthma
among children in preschool age (Lopez-Perez et al.,
2009). On the other hand, we cannot conclude that the increased positive
reactivity of the samples collected from patients with Upper Respiratory Tract
(URT) affections (47%) has any significant value since UTR affected patients
rarely underwent hospitalization and number of test samples were really restrictive
(Table 2).
In conclusion, the present study exploited two RT-PCR systems for detection and typing of RSV in 200 clinical samples collected from Riyadh, Saudi Arabia during the Winter season 2007-2008. Both RSV types were detected in the test samples with slight dominance of type A. Risk factors including male gender, young age (less than one year) and asthma may have the potential that favors RSV infection in Saudi Arabia children. Further utilization of the developed assays in tracking the RSV infected cases on spatial and temporal bases will provide significant information about the virus infection, disease progression and spread.
|
REFERENCES |
Al-Hajjar, S., J. Akhter, S. Al-Jumaahand H. Qadri, 1998. Respiratory viruses in children attending a major referral centre in Saudi Arabia. Ann. Trop. Paediatr., 18: 87-92. Direct Link |
Al-Shehri, M.A., A. Sadeq, and K. Quli, 2006. Bronchiolitis in Abha, Southwest Saudi Arabia: Viral etiology and predictors for hospital admission. West. Afr. J. Med., 24: 299-304. Direct Link |
Anderson, L.J., J.C. Hierholzer, C. Tsou, R.M. Hendry, B.F. Fernie, Y. Stone and K. McIntosh, 1985. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis., 151: 626-633.
Bakir, T.M., M. Halawani and S. Ramia, 1998. Viral aetiology and epidemiology of acute respiratory infections in hospitalized Saudi children. J. Trop. Pediatr., 44: 100-103. Direct Link |
Barr, F.E., N.R. Patel and C.J. Newth, 2000. The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchiolitis. J. Pediatr., 136: 699-700. Direct Link |
Bellau-Pujol, S., A. Vabret, L. Legrand, J. Dina and S. Gouarin et al., 2005. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J. Virol. Methods, 126: 53-63. CrossRef |
Boyce, T.G., B.G. Mellen, E.F. Mitchel, P.F. Wright and M.R. Griffin, 2000. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J. Pediatr., 137: 865-870. CrossRef |
Cane, P.A. and C.R. Pringle, 1991. Respiratory syncytial virus heterogeneity during an epidemic: Analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). J. Gen. Virol., 72: 349-357. CrossRef |
Collins, P.L., R.A. Olmsted and P.R. Johnson, 1990. The small hydrophobic protein of human respiratory syncytial virus: Comparison between antigenic subgroups A and B. J. Gen. Virol., 71: 1571-1576. Direct Link |
Couch, R.B., J.A. Englund and E. Whimbey, 1997. Respiratory viral infections in immunocompetent and immunocompromised persons. Am. J. Med., 102: 2-9. Direct Link |
De Vincenzo, J.P., 2007. A new direction in understanding the pathogenesis of respiratory syncytial virus bronchiolitis: How real infants suffer. J. Infect. Dis., 195: 1084-1086.
Deiman, B., C. Schrover, C. Mooreb, D. Westmoreland and P. van-de-Wiel, 2007. Rapid and highly sensitive qualitative real-time assay for detection of respiratory syncytial virus A and B using NASBA and molecular beacon technology. J. Virol. Meth., 146: 29-35. CrossRef |
Dewhurst-Maridor G., V. Simonet, J.E. Bornand, L.P. Nicod and J.C. Pache, 2004. Development of a quantitative TaqMan RT-PCR for respiratory syncytial virus. J. Virol. Meth., 120: 41-49. CrossRef |
Dimmock, N.J., A.J. Easton and K.N. Leppard, 2007. Introduction to Modern Virology. 6th Edn., Blackwell Publishing, USA.
Espy, M.J., J.R. Uhl, L.M. Sloan, S.P. Buckwalter and M.F. Jones et al., 2006. Real-time PCR in clinical microbiology: Applications for routine laboratory testing. Clin. Microbiol. Rev., 19: 165-256. CrossRef |
Falsey A.R., P.A. Hennessey, M.A. Formica, C. Cox and E.E. Walsh, 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med., 352: 1749-1759. Direct Link |
Falsey, A.R., M.A. Formica and E.E. Walsh, 2002. Diagnosis of respiratory syncytial virus infection: Comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J. Clin. Microbiol., 40: 817-820.
Fisher, R.G., W.C. Gruber, K.M. Edwards, G.W. Reed and S.J. Tollefson et al., 1997. Twenty years of outpatient respiratory syncytial virus infection: A framework for vaccine efficacy trials. Pediatrics, 99: E7-E7. CrossRef | Direct Link |
Fixler, D.E., 1996. Respiratory syncytial virus infection in children with congenital heart disease: A review. Pediatr. Cardiol., 17: 163-168. CrossRef |
Gerna, G., G. Campanini, V. Rognoni, A. Marchi, F. Rovida, A. Piralla and E. Percivalle, 2008. Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy. J. Clin. Virol., 41: 45-48. CrossRef |
Glezen, W.P., L.H. Taber, A.L. Frank and J.A. Kasel, 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child, 140: 543-546.
Han, L.L., J.P. Alexander and L.J. Anderson, 1999. Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden. J. Infect. Dis., 179: 25-30. Direct Link |
Heikkinen, T., J. Marttila, A. Salmi and O. Ruuskanen, 2002. Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J. Clin. Microbiol., 40: 4337-4339. Direct Link |
Hoffman, S.J., F.R. Laham and F.P. Polack, 2004. Mechanisms of illness during respiratory syncytial virus infection: The lungs, the virus and the immune response. Microbes. Infect., 6: 767-772. CrossRef |
Holberg, C.J., A.L. Wright, F.D. Martinez, C.G. Ray, L.M. Taussig and M.D. Lebowitz, 1991. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am. J. Epidemiol., 133: 1135-1151. Direct Link |
Hu, A., M. Colella, J.S. Tam, R. Rappaport and S.M. Cheng, 2003. Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J. Clin. Microbiol., 41: 149-154. Direct Link |
Iwane, M.K., K.M. Edwards, P.G. Szilagyi, M.P.H. Frances and J. Walker et al., 2004. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and Parainfluenza viruses among young children. Pediatrics, 113: 1758-1764. CrossRef | Direct Link |
Jamjoom, G.A., A.M. Al-Semrani, A. Board, A.R. Al-Frayh, F. Artz and K.F. Al-Mobaireek, 1993. Respiratory syncytial virus infection in young children hospitalized with respiratory illness in Riyadh. J. Trop. Pediatr., 39: 346-349. Direct Link |
Johnson, P.R., M.K. Spriggs, R.A. Olmsted and P.L. Collins, 1987. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: Extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA., 84: 5625-5629. Direct Link |
Johnston, S.L. and C.S. Siegel, 1990. Evaluation of direct immunofluorescence, enzyme immunoassay, centrifugation culture and conventional culture for the detection of respiratory syncytial virus. J. Clin. Microbiol., 28: 2394-2397. Direct Link |
Kafetzis, D.A., 2004. Prophylaxis, therapy and prevention of viral respiratory infections. Paediatr. Resp. Rev., 5: S185-S189.
Kim, H.W., J.O. Arrobio, C.D. Brandt, B.C. Jeffries and G. Pyleset al., 1973. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am. J. Epidemiol., 98: 216-225. Direct Link |
Kitchin, P.A., 1990. Clinical applications of the polymerase chain reaction. Int. J. Stud. AIDS, 1: 161-173.
Kuypers, J., N. Wright, J. Ferrenberg, M.L. Huang, A. Cent, L. Corey and R. Morrow, 2006. Comparison of real-time PCR assays with fluorescent antibody assays for diagnosis of respiratory virus infections in children. J. Clin. Microbiol., 44: 2382-2388. CrossRef | Direct Link |
Lopez Perez, G., B.M. Morfin Maciel, N. Navarrete and A Aguirre, 2009. Identification of influenza, parainfluenza, adenovirus and respiratory syncytial virus during rhinopharyngitis in a group of Mexican children with asthma and wheezing. Rev. Alerg. Mex., 56: 86-91.
Meissner, H.C., 2003. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr. Infect. Dis. J., 22: S40-S45.
Mentel, R., U. Ilgert, U. Wegner, K. Zimmermann, R. Bruns and L. Gurtler, 2005. Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children. Med. Microbiol. Immunol., 194: 67-71. CrossRef |
Meqdam, M.M. and S.H. Subaih, 2006. Rapid detectionand clinical features of infants and young children with acute lower respiratory tract infection due to respiratory syncytial virus. FEMS Immunol. Med. Microbiol., 47: 129-133. CrossRef |
Mlinaric-Galinovic, G., A.R. Falsey and E.E. Walsh, 1996. Respiratory syncytial virus infection in the elderly. Eur. J. Clin. Microbiol. Infect. Dis., 15: 777-781. CrossRef |
Mufson, M., C. Orvell, B. Rafnar and E. Norrby, 1985. Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol., 66: 2111-2124. Direct Link |
Nadder, T.S. and M.R. Langley, 2001. The new millennium laboratory: Molecular diagnostics goes clinical. Clin. Lab. Sci., 14: 252-259. Direct Link |
O'Shea, M.K. and P.A. Canea, 2004. Development of a highly sensitive semi-quantitative real-time PCR and molecular beacon probe assay for the detection of respiratory syncytial virus. J. Virol. Method., 118: 101-110. CrossRef |
Osiowy, C., 1998. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay. J. Clin. Microbiol., 36: 3149-3154. Direct Link |
Papadopoulos, N., D. Gourgiotis, A. Javadyan, A. Bossios and K. Kallergi et al., 2004. Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants?. Resp. Med., 98: 879-882. CrossRef |
Peret, T.C., C.B. Hall, K.C. Schnabel, J.A. Golub and L.J. Anderson, 1998. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J. Gen. Virol., 79: 2221-2229. Direct Link |
Riffault, S., C. Dubuquoy, N. Castagne, E. Baranowski, B. Charley and J.F. Eleouet, 2006. Replication of Bovine respiratory syncytial virus in murine cells depends on type I interferon-receptor functionality. J. Gen. Virol., 87: 2145-2148. CrossRef | Direct Link |
Slinger, R., R. Milk, I. Gaboury and F. Diaz-Mitoma, 2004. Evaluation of the QuickLab RSV test, a new rapid lateral-flow immunoassay for detection of respiratory syncytial virus antigen. J. Clin. Microbiol., 42: 3731-3733. Direct Link |
Templeton, K.E., S.A. Scheltinga, M.F. Beersma, Kroes, A.C. and E.C.Claas, 2004. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus and parainfluenza viruses 1, 2, 3 and 4. J. Clin. Microbiol., 42: 1564-1569. Direct Link |
Vandesompele, J., A. De Paepe and F. Speleman, 2002. Elimination of primer-dimer artifacts and genomic co-amplification using a two-step SYBR green-I real-time RT-PCR. Anal. Biochem., 303: 95-98. CrossRef |
Walsh, E.E., K.M. McConnochie, C.E. Long and C.B. Hall, 1997. Severity of respiratory syncytial virus infection is related to virus strain. J. Infect. Dis., 175: 814-820. Direct Link |
Wang, E.E. and B.J. Law, 1998. Respiratory syncytial virus infection in pediatric patients. Sem. Pediatr. Infect. Dis., 9: 146-153.
Welliver, R.C., 1988. Detection, pathogenesis and therapy of respiratory syncytial virus infections. Clin. Microbiol. Rev., 1: 27-39. Direct Link |
Whimbey, E., R.E. Champlin, R.B. Couch, J.A. Englund and J.M. Goodrich et al., 1996. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin. Infect. Dis., 22: 778-782.
White, L.J., M. Waris, P.A. Cane, D.J. Nokes and G.F. Medley, 2005. The transmission dynamics of groups A and B human respiratory syncytial virus (HRSV) in England and Wales and Finland: Seasonality and cross-protection. Epidemiol. Infect., 133: 279-289. CrossRef |
Wilson, S.D., B.B. Dahl and R.D. Wells, 2002. An evidence-based clinical pathway for bronchiolitis safely reduces antibiotic overuse. Am. J. Med. Qual., 17: 195-199. CrossRef | Direct Link |
Yamada, A., L. Lama and J.S. Tam, 2004. Typing and subtyping of influenza viruses and respiratory syncytial viruses by multiplex RT-PCR. Intl. Congr. Ser., 1263: 381-385. CrossRef |
|
|
|
 |